MediWound Ltd. (MDWD)
NASDAQ: MDWD · IEX Real-Time Price · USD
18.60
-2.29 (-10.96%)
At close: Jul 19, 2024, 4:00 PM
18.70
+0.10 (0.54%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
MediWound Revenue
MediWound had revenue of $19.85M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $4.96M with 30.67% year-over-year growth. In the year 2023, MediWound had annual revenue of $18.69M.
Revenue (ttm)
$19.85M
Revenue Growth
-23.32%
P/S Ratio
8.70
Revenue / Employee
$198,510
Employees
100
Market Cap
172.67M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 18.69M | -7.81M | -29.48% |
Dec 31, 2022 | 26.50M | 2.73M | 11.50% |
Dec 31, 2021 | 23.76M | 2.00M | 9.19% |
Dec 31, 2020 | 21.76M | -10.03M | -31.54% |
Dec 31, 2019 | 31.79M | 28.39M | 834.70% |
Dec 31, 2018 | 3.40M | 905.00K | 36.26% |
Dec 31, 2017 | 2.50M | 938.00K | 60.21% |
Dec 31, 2016 | 1.56M | 957.00K | 159.23% |
Dec 31, 2015 | 601.00K | 342.00K | 132.05% |
Dec 31, 2014 | 259.00K | - | - |
Dec 31, 2013 | 0 | - | - |
Dec 31, 2012 | 0 | - | - |
Dec 31, 2011 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Accuray | 430.55M |
Puma Biotechnology | 226.63M |
Rigel Pharmaceuticals | 120.35M |
Innate Pharma | 68.49M |
Metagenomi | 47.26M |
Fennec Pharmaceuticals | 44.95M |
MDWD News
- 6 days ago - MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program - GlobeNewsWire
- 7 days ago - Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd - PRNewsWire
- 7 days ago - MediWound Announces $25 Million Strategic Private Placement Financing - GlobeNewsWire
- 7 weeks ago - MediWound Reports First Quarter 2024 Financial Results and Provides Company Update - GlobeNewsWire
- 2 months ago - MediWound to Report First Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences - GlobeNewsWire
- 4 months ago - MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update - GlobeNewsWire
- 4 months ago - MediWound to Report Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire